Common name
N-ethylpyrazine-2-carboxamide
IUPAC name
N-ethylpyrazine-2-carboxamide
SMILES
C(=O)(NCC)c1nccnc1
Common name
N-ethylpyrazine-2-carboxamide
IUPAC name
N-ethylpyrazine-2-carboxamide
SMILES
C(=O)(NCC)c1nccnc1
INCHI
InChI=1S/C7H9N3O/c1-2-9-7(11)6-5-8-3-4-10-6/h3-5H,2H2,1H3,(H,9,11)
FORMULA
C7H9N3O
Common name
N-ethylpyrazine-2-carboxamide
IUPAC name
N-ethylpyrazine-2-carboxamide
Molecular weight
151.166
clogP
0.699
clogS
-1.973
Frequency
0.0003
HBond Acceptor
3
HBond Donor
1
Total PolarSurface Area
54.88
Number of Rings
1
Rotatable Bond
2
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00077 | Bortezomib |
|
Antineoplastic Agents; Antineoplastic and Immunomodulating Agents; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies. |
1 ,
1
